Swiggy: Co's Stock To Get 14 BPS Boost In Index Weight After QIP, Expected USD 144 Million Buying Flow.

TATA Consultancy Services: Expands Cooperation With Aviva UK To Oversee Extra 1.1 Million Policies; Total Managed Policies Now Surpass 6.5 Million; Aims To Improve Customer Experience With Digital Tools.

Sammaan Capital: Company Denies Any Connection To Mr. Gehlaut In Allegations Made In FIR, As Per Affidavit From Delhi Police's EOW.

Sammaan Capital: Sameer Gehlot and His Team Accused of Intentional Fraud - Zee Business

Sammaan Capital: FIR Launched Against Co - Zee Business

Maruti: Company Exports Over 10,000 EVs, Aiming for Sales in More Than 100 Countries - ETNOW

HBL Engineering: Ships 1,659 Out Of 2,200 Loco TCAS Units By December 13, 2025; 541 Units Cancelled; Next Year’s Demand Projected At 18,429 Units

Clean Science And Technology: Starts Commercial Production Of Hydroquinone And Catechol, Supporting Import Substitution And Enhancing Market Share.

Patel Engineering Ltd: Finalizes MOU With Arunachal Pradesh Government For 144 MW Gongri Hydropower Project Worth ₹1,700 Crores; Expected To Finish In Four Years

Granules India: Board Meeting Set For December 23, 2025, To Discuss Fundraising Through Preferential Issue And Decide On Issue Price

Tata Power: 5% EPS Impact Because Of Coal Tax By Indonesia || Tata Power’S Fy27-28 EPS Would Be Impacted By 4-5% - Morgan Stanley

Indigo: Co-CEO Announces 2,200 Daily Flights as of Today

Indigo: Co-CEO States That The Toughest Times Are Over

Unicommerce Esolutions Ltd: Appoints Gaurav Juneja As Senior Management Personnel From December 18, 2025; He Was Previously Chief Revenue Officer At Kapture.cx.

Max Healthcare Institute: Board Approves Share Purchase Agreement For Full Acquisition Of Yerawada Properties Private Limited; Plans To Build A ~450 Bedded Super Specialty Hospital In Pune With An Investment Of ₹1,020 Crore

Alembic Pharmaceuticals: Wins Final USFDA Approval For Travoprost Ophthalmic Solution USP, 0.004%, Aimed At Lowering High Intraocular Pressure; Market Estimated At $61 Million.

Alembic Pharmaceuticals: Wins Final USFDA Approval For Travoprost Ophthalmic Solution USP, 0.004%, Aimed At Lowering High Intraocular Pressure; Market Estimated At $61 Million.